Transmedics.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 38
What's happening
One to three months ago
-
SoFi, Robinhood, and Transmedics are mentioned as financial services companies and investment opportunities.Some support1 report1 development inside
-
Hernandez is named as the Chief Financial Officer (CFO) of TransMedics.Some support1 report
-
Transmedics is headquartered in Andover, MA.Some support4 reports
-
An investigation into corporate governance issues has begun concerning Transmedics at One World Trade Center.Some support1 report
Gone quiet
No new reports in 90+ days-
Transmedics, a US-based company, is investing in Germany and working to create an organ transplant network across Europe.Some support1 report
-
Nvidia and Transmedics are being discussed in the context of investment signals.Some support2 reports
-
The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.Some support3 reports
-
Transmedics trades on the Nasdaq stock exchange and files disclosures with the SEC.Some support3 reports
-
OrganOx Metra removed its air transport warning from its label.Speculative1 report
-
A sale decision was prompted by Transmedics' strong Q1 report, according to Headwaters Capital Management.Some support1 report
-
Veracyte and Transmedics operate within the same molecular diagnostic industry.Some support1 report1 development inside
-
OCS technology is cited as a key factor driving the growth of Transmedics.Some support4 reports1 development inside
-
OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.Some support5 reports
-
Transmedics is noted as being involved in the broader trend of AI changing the healthcare sector.Some support1 report
-
Transmedics entered international markets via a facility in Italy.Some support1 report
-
FDA approval is identified as a key regulatory catalyst for Transmedics.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Transmedics this week
News at the entities that move Transmedics most-
OCS StructuralCannabis products were listed with OCS and delivered to BC Cannabis Stores, with product reloading occurring in Saskatchewan.Moves Transmedics
-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Transmedics
-
Hernandez StructuralHernandez is running in a Democratic race in the Boyle Heights and Eagle Rock neighborhoods.Moves Transmedics
-
Italy StructuralFiscal concerns spread from France to Italy and Greece, while US rate hikes challenge Bank of Japan policy.Moves Transmedics
-
Needham & Company Mentioned togetherTD Cowen and Needham & Company boosted the price target and gave a 'buy' rating for Ultra Clean.Moves Transmedics
-
Nasdaq StructuralINmune Bio Inc. listed its shares on the stock exchange on July 9, 2026.Moves Transmedics
Connections
The 17 strongest of 38, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
OCS Structural
OCS technology is the core product driving Transmedics' growth and market operations in organ transplant procedures.
-
FDA Structural
Transmedics' products depend on FDA regulatory approvals and oversight for market operation.
-
Nasdaq Structural
Transmedics conducts its trading business on the Nasdaq stock exchange platform.
-
Italy Structural
Transmedics is establishing and utilizing a manufacturing plant in Italy.
-
London Health Sciences Centre Structural
LHS Centre provides the necessary Organ Care System for Transmedics' transplant operations.
-
Hernandez Structural
Hernandez holds the position of Chief Financial Officer at Transmedics.
-
SEC Structural
Transmedics operates under the regulatory oversight of the SEC, requiring formal financial disclosures.
-
Brian Johnston Transactional
Brian Johnston holds the role of Investor Contact for Transmedics.
Show all 17 connections
-
SoFi Mentioned together
Both SoFi and Transmedics are mentioned in the same context as investment opportunities.
-
Europe Shared context
Transmedics is conducting market expansion and establishing transplant networks within the European geographical context.
-
Andover Shared context
Transmedics is headquartered in Andover, Massachusetts.
-
Nvidia Mentioned together
Nvidia and Transmedics are co-mentioned as examples of investment opportunities and growth signals.
-
Needham & Company Mentioned together
Needham & Company provides analyst ratings and target price cuts for Transmedics.
-
Andover Shared context
TransMedics is headquartered in Andover, Massachusetts.
-
Massachusetts Shared context
Transmedics is headquartered in the state of Massachusetts.
-
One World Trade Center Shared context
The entities are linked in the context of a corporate governance investigation.
-
Boston Shared context
TransMedics is scheduled to participate in a conference held in Boston.
History
Events by the month they beganAugust 2026
1 eventJuly 2026
4 events- SoFi, Robinhood, and Transmedics are mentioned as financial services companies and investment opportunities.
- An investigation into corporate governance issues has begun concerning Transmedics at One World Trade Center.
- Transmedics, a US-based company, is investing in Germany and working to create an organ transplant network across Europe.
- Nvidia and Transmedics are being discussed in the context of investment signals.
June 2026
11 events- Transmedics is headquartered in Andover, MA.
- The FDA granted conditional IDE approval for TransMedics utilizing the OCS Heart System.
- Transmedics trades on the Nasdaq stock exchange and files disclosures with the SEC.
- OrganOx Metra removed its air transport warning from its label.
- A sale decision was prompted by Transmedics' strong Q1 report, according to Headwaters Capital Management.
- Veracyte and Transmedics operate within the same molecular diagnostic industry.
- OCS technology is cited as a key factor driving the growth of Transmedics.
- OCS technology was cited for keeping donated organs healthy and providing better outcomes for transplant recipients.
- Transmedics is noted as being involved in the broader trend of AI changing the healthcare sector.
- Transmedics entered international markets via a facility in Italy.
- FDA approval is identified as a key regulatory catalyst for Transmedics.